middle.news
How Nexsen Plans to Revolutionise GBS Testing with StrepSure® Global Rollout
8:34am on Thursday 26th of March, 2026 AEDT
•
Healthcare
Read Story
How Nexsen Plans to Revolutionise GBS Testing with StrepSure® Global Rollout
8:34am on Thursday 26th of March, 2026 AEDT
Key Points
FDA 510(k) submission targeted for Q4 2026
Early commercialisation initiatives underway in Hong Kong, Malaysia, and India
ISO 13485 certification expected by early Q3 2026
Manufacturing hub established in Hong Kong for global distribution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NEXSEN (ASX:NXN)
OPEN ARTICLE